2025
SJR Q1
JCR Q2 · 4,5
OA
147 matched articles
SCIE
Journal detail
Pharmacological Reports
- Publisher
- Springer Science and Business Media Deutschland GmbH
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
1734114022995684
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,016
- Quartile Q1
- H-Index 104
- Cites/doc 4,72
- Docs (3y) 329
- Cites (3y) 1.483
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 4,5
- 5Y JIF 4,2
- JCI 0,74
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
- Pharmacology Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,016 | 4,5 | 4,2 | 0,74 | Q2 | 104 |
| 2024 | Q1 | Q2 | 0,933 | 3,8 | 3,6 | 0,84 | Q2 | 100 |
| 2023 | Q2 | Q2 | 0,867 | 3,6 | 3,2 | 0,91 | Q2 | 100 |
| 2022 | Q2 | Q2 | 0,802 | 4,4 | 3,5 | 0,91 | Q2 | 100 |
| 2021 | Q2 | Q2 | 0,625 | 3,9 | 3,5 | 0,85 | Q2 | 100 |
| 2020 | Q2 | Q3 | 0,706 | 3 | 3,4 | 0,85 | Q2 | 100 |
| 2019 | Q2 | Q2 | 0,736 | 2,8 | 2,8 | 0,84 | Q2 | 100 |
| 2018 | — | Q2 | — | 2,8 | 2,8 | 0,9 | Q2 | — |
| 2017 | Q2 | Q2 | 0,773 | 2,8 | 2,7 | 0,86 | Q2 | 100 |
| 2016 | Q2 | Q2 | 0,866 | 2,6 | 2,5 | — | — | 100 |
| 2015 | Q2 | Q3 | 0,864 | 2,3 | 2,3 | — | — | 100 |
| 2014 | Q2 | Q3 | 0,747 | 1,9 | 2,2 | — | — | 100 |
| 2013 | Q2 | Q3 | 0,811 | 2,2 | 2,4 | — | — | 100 |
| 2012 | Q1 | Q3 | 0,838 | 2 | 2,2 | — | — | 100 |
| 2011 | Q1 | Q2 | 0,977 | 2,4 | 2,4 | — | — | 100 |
| 2010 | Q1 | Q2 | 0,817 | 2,5 | 2,2 | — | — | 100 |
| 2009 | — | Q3 | — | 2,1 | 2,2 | — | — | — |
| 2008 | — | Q3 | — | 2,2 | 2,3 | — | — | — |
| 2007 | — | Q2 | — | 2,3 | 2,3 | — | — | — |
| 2006 | — | Q3 | — | 1,1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 90/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 92/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 94/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 81/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 118/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 163/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 129/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 119/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 109/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 119/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 135/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 156/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 113/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 110/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 133/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 119/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 94/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 149/199 |